Polycystic kidney disease in patients on the renal transplant waiting list: Trends in hematocrit and survival

被引：20

作者：

Abbott K.C. ^{[1
,2
]}

Agodoa L.Y. ^{[3
]}

机构：

[1] Nephrology Service, Walter Reed Army Medical Center, Washington, DC

[2] Uniformed Serv. Univ. Health Sci., Bethesda, MD

[3] NIDDK, NIH, Bethesda, MD

来源：

BMC Nephrology | / 3卷 / 1期

关键词：

Age; Albumin; Caucasian; Complications; Dialysis; Dysrythmias; EPO; Female; Frequency; Hemoglobin; Mortality; Peritoneal dialysis; Polycystic kidney disease; Transplantation; USRDS; Weight;

D O I：

10.1186/1471-2369-3-7

中图分类号：

学科分类号：

摘要：

Background: The patient characteristics and mortality associated with autosomal dominant polycystic kidney disease (PKD) have not been characterized for a national sample of end stage renal disease (ESRD) patients on the renal transplant waiting list. Methods: 40,493 patients in the United States Renal Data System who were initiated on ESRD therapy between 1 April 1995 and 29 June 1999 and later enrolled on the renal transplant waiting list were analyzed in an historical cohort study of the relationship between hematocrit at the time of presentation to ESRD and survival (using Cox Regression) in patients with PKD as a cause of ESRD. Results: Hematocrit levels at presentation to ESRD increased significantly over more recent years of the study. Hematocrit rose in parallel in patients with and without PKD, but patients with PKD had consistently higher hemoglobin. PKD was independently associated with higher hematocrit in multiple linear regression analysis (p < 0.0001). In logistic regression, higher hematocrit was independently associated with PKD. In Cox Regression analysis, PKD was associated with statistically significant improved survival both in comparison with diabetic (hazard ratio, 0.64, 95% CI 0.53-0.77, p < 0.001) and non-diabetic (HR 0.68, 95% CI 0.56-0.82, p = 0.001) ESRD patients, adjusted for all other factors. Conclusions: Hematocrit at presentation to ESRD was significantly higher in patients with PKD compared with patients with other causes of ESRD. The survival advantage of PKD in ESRD persisted even adjusted for differences in hematocrit and in comparison with patients on the renal transplant waiting list.

引用

页码：1 / 6

页数：5

共 12 条

[1]

Perrone R.D., Ruthazer R., Terrin N.C., Survival after end-stage renal disease in autosomal dominant polycystic kidney disease: Contribution of extrarenal complications to mortality, Am J Kidney Dis, 38, pp. 777-784, (2001)

[2]

Fourtounas C., Panteris V., Valis D., Survival after end-stage renal disease in autosomal dominant polycystic kidney disease, Am J Kidney Dis, 39, (2002)

[3]

Abbott K.C., Agodoa L.Y., Polycystic kidney disease at end-stage renal disease in the United States: Patient characteristics and survival, Clin Nephrol, 57, pp. 208-214, (2002)

[4]

Longenecker J.C., Coresh J., Klag M.J., Levey A.S., Martin A.A., Fink N.E., Powe N.R., Validation of comorbid conditions on the end-stage renal disease medical evidence report: The CHOICE study. Choices for Healthy Outcomes in Caring for ESRD, J Am Soc Nephrol, 11, pp. 520-529, (2000)

[5]

Chandra M., Miller M.E., Garcia J.F., Mossey R.T., McVicar M., Serum immunoreactive erythropoietin levels in patients with polycystic kidney disease as compared with other hemodialysis patients, Nephron, 39, 1, pp. 26-29, (1985)

[6]

Rotellar C., Gelfand M.C., Polycystic kidneys do maintain good endocrine function, Med Hypotheses, 30, pp. 61-64, (1989)

[7]

Linblad A.S., Nolph K.D., Hematocrit values in the CAPD/CCPD population: A report of the National CAPD Registry, Perit Dial Int, 10, pp. 275-278, (1990)

[8]

Glicklich D., Kutcher R., Rosenblatt R., Barth R.H., Time-related increase in hematocrit on chronic hemodialysis: Uncertain role of renal cysts, Am J Kidney Dis, 15, pp. 46-54, (1990)

[9]

Hadimeri H., Johansson A.C., Haraldsson B., Nyberg G., CAPD in patients with autosomal dominant polycystic kidney disease, Perit Dial Int, 18, pp. 429-432, (1998)

[10]

Locatelli A.J., Marcos G.M., Gomez M.G., Alvarez S.A., DeBenedetti L.C., Comparing peritonitis in continuous ambulatory peritoneal dialysis patients versus automated peritoneal dialysis patients, Adv Perit Dial, 15, pp. 193-196, (1999)

← 1 2 →